GLP Watchdog

Hers vs SkinnyRx

Hers has an open FDA warning letter dated September 9, 2025. SkinnyRx has an open FDA warning letter dated February 20, 2026. No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Hers / SkinnyRx

Hers logo

Hers

6.8/10

Featured pick (affiliate partner)

SkinnyRx logo

SkinnyRx

6.3/10

FDA warning letters
Pharmacy
None named in our record
Lowest standing price
$199/moCompounded semaglutide injection
$248/moBrand-name semaglutide pill
States
All 50 states
47 states
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit Hers
Visit SkinnyRx

SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hers pays us nothing. The scores are computed the same way for both and are shown as computed (Hers 6.8, SkinnyRx 6.3). How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. SkinnyRx has an open FDA warning letter dated February 20, 2026.

  2. 02

    Hers names three pharmacies. SkinnyRx names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.

  4. 04

    Only SkinnyRx lists a price for compounded tirzepatide injection, brand-name semaglutide pen and compounded oral semaglutide.

  5. 05

    Hers covers three states SkinnyRx does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Hers

SkinnyRx

Compounded semaglutide injection

$199/mo

$2,388 a year

$99/mo

first month only; not compared

Brand-name tirzepatide pen

$299/mo

medication only, membership extra; not compared

$1,400/mo

$16,800 a year

Compounded tirzepatide injection
Not sold or not priced

$99/mo

first month only; not compared

Brand-name semaglutide pen
Not sold or not priced

$1,400/mo

$16,800 a year

Compounded oral semaglutide
Not sold or not priced

$149/mo

first month only; not compared

Compounded oral tirzepatide
Not sold or not priced

$199/mo

first month only; not compared

Brand-name semaglutide pill
Not sold or not priced

$248/mo

$2,976 a year

Foundayo (orforglipron) pill
Not sold or not priced

$248/mo

$2,976 a year

Price includes
Medication
Medication, clinician visits, shipping
Billed separately
Clinician visits, coaching
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None stated; subscriptions auto-renew until canceled at least 5 days before the renewal date
Refunds
No refund guaranteed once the pharmacy has processed an order
Full refund before a provider completes the prescription review; no refunds for partially used subscription periods

Read off each seller’s own pages. Hers: September 28, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Hers

6.8/10
  • Names its compounding pharmacy
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

The case for SkinnyRx

6.3/10
Featured pick (affiliate partner)
  • Sells compounded tirzepatide injection and brand-name semaglutide pen, which Hers does not price
  • Price includes clinician visits
  • Open FDA warning letter, February 20, 2026
  • Names no compounding pharmacy
Visit SkinnyRx

Scores

Hers 6.8 · SkinnyRx 6.3 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
5.6

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

7.0A
vs
B
2.0

Accessibility10%

10.0A
vs
B
9.5

Support10%

3.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Hers vs SkinnyRx: questions

Hers has an open FDA warning letter dated September 9, 2025. SkinnyRx has an open FDA warning letter dated February 20, 2026. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. SkinnyRx names no compounding pharmacy in our record.
No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order. SkinnyRx states you can cancel at any time; refunds: full refund before a provider completes the prescription review; no refunds for partially used subscription periods.
SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hers pays us nothing. The scores are computed the same way for both and are shown as computed (Hers 6.8, SkinnyRx 6.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks